Announcements and Notices - [Other - Business Update]

Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company's products include antibiotics, anti-cancer medications and anti-stroke medications.

Voluntary Announcement - Approval For Marketing Of Sanbexin Sublingual Tablets In China By The National Medical Products Administration

Next Day Disclosure Returns - [Share Buyback]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Simcere Pharmaceutical Group (2096 HK)

Voluntary Announcement - Approval For Marketing Of Sanbexin Sublingual Tablets In China By The National Medical Products Administration

Next Day Disclosure Return

Voluntary Announcement - The Inclusion Of Three Innovative Drugs, Cosela, Enlituo And Sanbexin, In The New National Reimbursement Drug List

Next Day Disclosure Return

Next Day Disclosure Return

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)